Clive Loveday

Overview

Best Publications

• Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel

  Martin S. Hirsch;Françoise Brun-Vézinet;Richard T. D'Aquila;Scott M. Hammer

  829
  Citations

• Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

  M S Hirsch;B Conway;R T D'Aquila;V A Johnson

  741
  Citations

• Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

  Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  674
  Citations

• Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)

  Rob Schuurman;Monique Nijhuis;Remko van Leeuwen;Pauline Schipper

  617
  Citations

• Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

  Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  568
  Citations

• The epic Project: Developing National Evidence-based Guidelines for Preventing Healthcare associated Infections

  RJ Pratt;C Pellowe;HP Loveday;N Robinson

  471
  Citations

• The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission

  Mari Rose A. Aplasca;David Siegel;Jeffrey S. Mandel;Rosemarie T. Santana-Arciaga

  469
  Citations

• Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.

  Helen L. Devereux;Mike Youle;Margaret A. Johnson;Clive Loveday

  391
  Citations

• Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection

  Martin S. Hirsch;Scott M. Hammer;Victoria A. Johnson;Daniel R. Kuritzkes

  332
  Citations

• Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

  Amanda Mocroft;Michael Youle;Antonia Moore;Caroline A. Sabin

  319
  Citations

• Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients : A randomized controlled comparison with zidovudine monotherapy

  Christine Katlama;Didier Ingrand;Clive Loveday;Nathan Clumeck

  229
  Citations

• Hepatitis C virus: evidence for sexual transmission.

  R. S. Tedder;R. J. C. Gilson;M. Briggs;C. Loveday

  204
  Citations

• Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice.

  A.N. Phillips;D. Dunn;C. Sabin;A. Pozniak

  200
  Citations

• Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

  Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis

  174
  Citations

• Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients : A randomized controlled comparison with zidovudine monotherapy

  Schlomo Staszewski;Clive Loveday;Juan J. Picazo;Pierre Dellamonica

  164
  Citations

• HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial

  Francoise Brun-Vezinet;Charles Boucher;Clive Loveday;Diane Descamps

  156
  Citations

• Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma.

  R Schuurman;D Descamps;G J Weverling;S Kaye

  153
  Citations

• Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting

  Miller;Anne-Mieke Vandamme;C Loveday;S Staszewski

  151
  Citations

• Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations.

  Helen L. Devereux;Vincent C. Emery;Margaret A. Johnson;Clive Loveday

  147
  Citations

• Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.

  Alessandro Cozzi-Lepri;Andrew N Phillips;Lidia Ruiz;Bonaventura Clotet

  145
  Citations

• The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

  David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  141
  Citations

• PREVALENCE OF ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS, GONORRHOEA RATES, AND CHANGED SEXUAL BEHAVIOUR IN HOMOSEXUAL MEN IN LONDON

  Unknown

  136
  Citations

• HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy

  C Loveday;S Kaye;M Semple;V Ayliffe

  117
  Citations

• Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population.

  Amanda Mocroft;Helen Devereux;Sabine Kinloch-de-Loes;Debbie Wilson

  114
  Citations